Copyright
        ©2006 Baishideng Publishing Group Co.
    
    
        World J Gastroenterol. Mar 7, 2006; 12(9): 1412-1415
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1412
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1412
            Table 1 Changes of paclitaxel concentrations over time in plasma and ascites (ng/mL).
        
    | 0 | 4 | 8 | 12 | 24 | 36 | 48 | 60 | 72 | 84(h) | |
| Case 1 (60mg/m2) | ||||||||||
| Plasma | 1240 | - | 112 | - | 55 | 40 | 26 | 20 | - | |
| Ascites | 19 | 30 | 50 | 54 | 62 | 40 | 25 | 20 | 20 | |
| Case 2 (80mg/m2) | ||||||||||
| Plasma | 468 | - | 203 | - | 55 | 31 | 27 | 15 | 14 | |
| Ascites | 11 | 17 | 27 | 30 | 27 | 23 | 19 | 17 | 12 | |
- Citation: Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, Araki K. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol 2006; 12(9): 1412-1415
- URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1412.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i9.1412

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        